Masahiro Okumura Selected Research

Masahiro Okumura Research Topics

Disease

16	Neoplasms (Cancer) 04/2022 - 03/2003
5	Osteoarthritis 01/2022 - 09/2012
3	Osteosarcoma (Osteogenic Sarcoma) 03/2022 - 01/2013
3	Joint Diseases (Joint Disease) 05/2018 - 03/2003
3	Histiocytic Sarcoma 09/2015 - 01/2013
2	Transitional Cell Carcinoma 03/2022 - 04/2015
2	Bone Resorption 01/2022 - 05/2018
2	Inflammation (Inflammations) 01/2022 - 08/2012
1	Osteoporosis 01/2022
1	Iron Overload 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Anemia 01/2022
1	Intussusception 11/2021
1	Colorectal Neoplasms (Colorectal Cancer) 11/2020
1	Carcinogenesis 06/2019
1	Experimental Arthritis 02/2019
1	Arthritis (Polyarthritis) 02/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Hematuria 01/2019
1	Urethral Obstruction 01/2019
1	Urinary Incontinence 01/2019
1	Dysuria 01/2019
1	Bone Diseases (Bone Disease) 05/2018
1	Carcinoid Tumor (Carcinoid) 11/2015
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2015
1	Cystitis 04/2015
1	Seminoma 03/2015
1	Rabies (Hydrophobia) 06/2014
1	Melanoma (Melanoma, Malignant) 01/2013
1	Acute Pain 08/2012
1	Pain (Aches) 08/2012
1	Synovitis 06/2012
1	Osteochondrosis (Osgood Schlatter Disease) 02/2010
1	Intra-Articular Fractures 02/2010
1	Neoplasm Metastasis (Metastasis) 08/2005

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 04/2022 - 09/2003
3	Pentosan Sulfuric Polyester (Pentosan Polysulfate)FDA Link 01/2022 - 02/2019
3	Messenger RNA (mRNA)IBA 02/2019 - 08/2005
3	SurvivinIBA 09/2015 - 01/2013
3	Biological ProductsIBA 09/2015 - 01/2013
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2009 - 11/2006
3	Verteporfin (Visudyne)FDA Link 02/2009 - 11/2006
2	AcidsIBA 01/2022 - 05/2018
2	Phosphates (Orthophosphate)IBA 01/2022 - 05/2018
2	tartaric acid (tartrate)FDA Link 01/2022 - 05/2018
2	Collagen Type II (Type II Collagen)IBA 02/2019 - 02/2010
2	Biomarkers (Surrogate Marker)IBA 02/2019 - 02/2010
2	sepantroniumIBA 09/2015 - 04/2015
2	Small Interfering RNA (siRNA)IBA 04/2015 - 01/2013
2	carprofen FDA Link 08/2013 - 09/2012
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 08/2013 - 08/2012
2	robenacoxibIBA 09/2012 - 08/2012
1	gedatolisibIBA 04/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2022
1	TOR Serine-Threonine KinasesIBA 04/2022
1	MTOR InhibitorsIBA 04/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2022
1	HepcidinsIBA 01/2022
1	Heparin (Liquaemin)FDA LinkGeneric 01/2022
1	IronIBA 01/2022
1	CaspasesIBA 12/2021
1	trametinibIBA 11/2020
1	Polysaccharides (Glycans)IBA 08/2020
1	Carrier Proteins (Binding Protein)IBA 06/2019
1	CytokinesIBA 02/2019
1	incomplete Freund's adjuvantIBA 02/2019
1	RANK LigandIBA 05/2018
1	Macrophage Colony-Stimulating FactorIBA 05/2018
1	Pharmaceutical PreparationsIBA 05/2018
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 05/2018
1	Octreotide (Sandostatin)FDA LinkGeneric 11/2015
1	Chromogranin AIBA 11/2015
1	GastrinsIBA 11/2015
1	ChromatinIBA 04/2015
1	Nuclear Proteins (Protein, Nuclear)IBA 04/2015
1	CXC ChemokinesIBA 03/2015
1	VaccinesIBA 06/2014
1	Meloxicam (Mobic)FDA LinkGeneric 08/2013
1	Annexin A5IBA 01/2013
1	TabletsIBA 09/2012
1	Ketoprofen (Orudis)FDA LinkGeneric 08/2012
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2012
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 06/2012
1	tepoxalinIBA 06/2012
1	procollagen type II carboxy-terminal peptideIBA 02/2010
1	Matrix Metalloproteinases (MMPs)IBA 08/2005

Therapy/Procedure

6	Therapeutics 03/2022 - 03/2003
4	Transplantation 03/2019 - 03/2003
3	Photochemotherapy (Photodynamic Therapy) 02/2009 - 11/2006
2	Lasers (Laser) 02/2009 - 04/2007
2	Semiconductor Lasers 02/2009 - 09/2004
1	Traction 11/2021
1	Cell Transplantation 01/2021
1	Heterologous Transplantation (Xenotransplantation) 06/2019
1	Intradermal Injections 02/2019
1	Palliative Care (Palliative Therapy) 01/2019
1	Aftercare (After-Treatment) 01/2019
1	Microspheres (Microsphere) 01/2013
1	Pain Management 06/2012
1	Intravenous Infusions 02/2009